×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
所有
MeSH descriptor
Mesh Subheading
Mesh Supplementary Concept
Mesh Pharmacological Action
search
搜索
清除所有
MeSH 搜索器
AND
OR
加入MeSH搜索引擎
搜索PubMed论文列
清除所有
Pyrimethamine
One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.
推出的年份:
副标题
administration and dosage
adverse effects
agonists
analogs and derivatives
analysis
antagonists and inhibitors
blood
cerebrospinal fluid
chemical synthesis
chemistry
classification
economics
history
immunology
isolation and purification
metabolism
pharmacokinetics
pharmacology
poisoning
radiation effects
standards
supply and distribution
therapeutic use
toxicity
urine
树号:
D03.383.742.675
MeSH 单一 ID:
D011739
进入的组:
Malocide
Tindurine
Chloridin
Daraprim
药理作用*:
Antimalarials
Antiprotozoal Agents
Folic Acid Antagonists
All MeSH Categories
Chemicals and Drugs Category
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyrimidines [D03.383.742]
Bosentan [D03.383.742.060]
Buspirone [D03.383.742.120]
Dasatinib [D03.383.742.148]
Dipyridamole [D03.383.742.175]
add_circle
Epirizole [D03.383.742.200]
Hexetidine [D03.383.742.279]
Imatinib Mesylate [D03.383.742.349]
Minoxidil [D03.383.742.418]
Mopidamol [D03.383.742.430]
Morantel [D03.383.742.440]
Nicarbazin [D03.383.742.470]
Oxypurinol [D03.383.742.550]
Paliperidone Palmitate [D03.383.742.592]
Pyrantel [D03.383.742.634]
add_circle
Pyrimethamine [D03.383.742.675]
Pyrimidine Nucleosides [D03.383.742.680]
add_circle
Pyrimidine Nucleotides [D03.383.742.686]
add_circle
Pyrimidinones [D03.383.742.698]
add_circle
Pyrithiamine [D03.383.742.715]
Rilpivirine [D03.383.742.755]
add_circle
Rosuvastatin Calcium [D03.383.742.775]
Thiamine [D03.383.742.795]
add_circle
Trapidil [D03.383.742.875]
Trimethoprim [D03.383.742.906]
add_circle
thumb_up
Like
share
分享
favorite
书签
0
0
0
0
0
0
0
留言 (
0
)
gif
登入或註冊以發表你的留言
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin
留言 (0)